Elizabeth Warren and the FTC Are the Least of Amgen’s Problems

The biotech company is facing a patent cliff scarier than Washington’s actions

Sen. Elizabeth Warren wrote a blistering letter opposing Amgen’s acquisition of Horizon Therapeutics. Photo: Al Drago/Bloomberg News

Amgen isn’t getting much love from Washington these days.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers
  • adidas:
    Sitewide: 30% OFF adidas Promo Code
  • Nike:
    60% Off running shoes and apparel at Nike without a promo code
  • Kohl's:
    Kohl's promo code: 30% off for Kohl's Rewards Members
  • Walmart:
    20% off your order with Walmart promo code
  • Target:
    Target Promo Code: 20% off Entire Order